AAPL   331.50 (+2.85%)
MSFT   187.20 (+2.34%)
FB   230.77 (+1.98%)
GOOGL   1,440.02 (+1.82%)
AMZN   2,483.00 (+0.91%)
NVDA   356.80 (+1.75%)
CGC   16.51 (-0.72%)
BABA   219.55 (+0.69%)
MU   53.72 (+4.88%)
GE   7.88 (+1.81%)
TSLA   885.66 (+2.46%)
AMD   53.10 (+0.89%)
T   32.77 (+3.05%)
ACB   13.94 (-2.04%)
F   7.34 (+5.46%)
GILD   76.75 (-1.02%)
DIS   124.82 (+0.91%)
NFLX   419.60 (+1.27%)
BAC   28.11 (+4.97%)
BA   205.43 (+11.47%)
AAPL   331.50 (+2.85%)
MSFT   187.20 (+2.34%)
FB   230.77 (+1.98%)
GOOGL   1,440.02 (+1.82%)
AMZN   2,483.00 (+0.91%)
NVDA   356.80 (+1.75%)
CGC   16.51 (-0.72%)
BABA   219.55 (+0.69%)
MU   53.72 (+4.88%)
GE   7.88 (+1.81%)
TSLA   885.66 (+2.46%)
AMD   53.10 (+0.89%)
T   32.77 (+3.05%)
ACB   13.94 (-2.04%)
F   7.34 (+5.46%)
GILD   76.75 (-1.02%)
DIS   124.82 (+0.91%)
NFLX   419.60 (+1.27%)
BAC   28.11 (+4.97%)
BA   205.43 (+11.47%)
AAPL   331.50 (+2.85%)
MSFT   187.20 (+2.34%)
FB   230.77 (+1.98%)
GOOGL   1,440.02 (+1.82%)
AMZN   2,483.00 (+0.91%)
NVDA   356.80 (+1.75%)
CGC   16.51 (-0.72%)
BABA   219.55 (+0.69%)
MU   53.72 (+4.88%)
GE   7.88 (+1.81%)
TSLA   885.66 (+2.46%)
AMD   53.10 (+0.89%)
T   32.77 (+3.05%)
ACB   13.94 (-2.04%)
F   7.34 (+5.46%)
GILD   76.75 (-1.02%)
DIS   124.82 (+0.91%)
NFLX   419.60 (+1.27%)
BAC   28.11 (+4.97%)
BA   205.43 (+11.47%)
AAPL   331.50 (+2.85%)
MSFT   187.20 (+2.34%)
FB   230.77 (+1.98%)
GOOGL   1,440.02 (+1.82%)
AMZN   2,483.00 (+0.91%)
NVDA   356.80 (+1.75%)
CGC   16.51 (-0.72%)
BABA   219.55 (+0.69%)
MU   53.72 (+4.88%)
GE   7.88 (+1.81%)
TSLA   885.66 (+2.46%)
AMD   53.10 (+0.89%)
T   32.77 (+3.05%)
ACB   13.94 (-2.04%)
F   7.34 (+5.46%)
GILD   76.75 (-1.02%)
DIS   124.82 (+0.91%)
NFLX   419.60 (+1.27%)
BAC   28.11 (+4.97%)
BA   205.43 (+11.47%)
Log in

NYSE:HRCHill-Rom Stock Price, Forecast & News

$101.98
+0.37 (+0.36 %)
(As of 06/5/2020 04:00 PM ET)
Add
Compare
Today's Range
$100.22
Now: $101.98
$102.08
50-Day Range
$97.92
MA: $105.17
$115.71
52-Week Range
$72.29
Now: $101.98
$117.50
Volume536,400 shs
Average Volume664,744 shs
Market Capitalization$6.79 billion
P/E Ratio46.78
Dividend Yield0.86%
Beta0.7
Hill-Rom Holdings, Inc. operates as a medical technology company worldwide. It operates in three segments: Patient Support Systems, Front Line Care, and Surgical Solutions. The company offers medical surgical beds, intensive care unit beds, and bariatric patient beds, lifts and other patient mobility devices, non-invasive therapeutic products and surfaces, and information technologies and software solutions; and medical equipment management services, as well as sells equipment service contracts for its capital equipment. It also provides patient monitoring and diagnostics products, such as blood pressure, physical assessment, vital signs monitoring, diagnostic cardiopulmonary, diabetic retinopathy screening, and thermometry products; and respiratory health products comprising Vest System, VitalCough System, MetaNeb System, and Monarch systems to assist patients in the mobilization of retained blockages. In addition, the company offers surgical solutions that include surgical tables, lights, and pendants; positioning devices for use in shoulder, hip, spinal, and lithotomy surgeries, as well as platform-neutral positioning accessories for operating room tables; and operating room surgical safety and accessory products, which comprise scalpels and blades, light handle systems, skin markers, and other disposable products. Further, it is involved in the sales and rental of products to acute and extended care facilities through direct sales force and distributors; sales and rental of products directly to patients in the home; and sales to primary care facilities through distributors. Additionally, the company offers continuum of clinical care, including acute care and primary care, as well as clinical research organizations. Hill-Rom Holdings, Inc. was founded in 1969 and is headquartered in Chicago, Illinois.
Read More
Hill-Rom logo

Beat the Market (BTM) Rank

Analyst Opinion: 2.5Community Rank: 2.5Dividend Strength: 4.2Insider Behavior: 1.0Valuation: 0.6 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

2.16 out of 5 stars


Industry, Sector and Symbol

Industry Surgical & medical instruments
Sub-IndustryHealth Care Equipment
SectorMedical
CUSIP43147510
Phone312-819-7200

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$2.91 billion
Cash Flow$8.20 per share
Book Value$23.55 per share

Profitability

Net Income$152.20 million

Miscellaneous

Employees10,000
Market Cap$6.79 billion
Next Earnings Date8/7/2020 (Estimated)
OptionableOptionable

Receive HRC News and Ratings via Email

Sign-up to receive the latest news and ratings for HRC and its competitors with MarketBeat's FREE daily newsletter.

Hill-Rom (NYSE:HRC) Frequently Asked Questions

How has Hill-Rom's stock been impacted by COVID-19 (Coronavirus)?

Hill-Rom's stock was trading at $89.15 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization (WHO). Since then, HRC stock has increased by 14.4% and is now trading at $101.98. View which stocks have been most impacted by Coronavirus.

Do Wall Street analysts recommend investors buy shares of Hill-Rom?

5 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Hill-Rom in the last year. There are currently 5 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for Hill-Rom.

When is Hill-Rom's next earnings date?

Hill-Rom is scheduled to release its next quarterly earnings announcement on Friday, August 7th 2020. View our earnings forecast for Hill-Rom.

How were Hill-Rom's earnings last quarter?

Hill-Rom Holdings, Inc. (NYSE:HRC) released its quarterly earnings data on Friday, May, 1st. The medical technology company reported $1.28 earnings per share for the quarter, beating the Thomson Reuters' consensus estimate of $1.15 by $0.13. The medical technology company earned $723.20 million during the quarter, compared to the consensus estimate of $701.72 million. Hill-Rom had a return on equity of 22.60% and a net margin of 5.04%. The firm's revenue for the quarter was up 1.3% compared to the same quarter last year. During the same quarter last year, the firm earned $1.14 earnings per share. View Hill-Rom's earnings history.

How often does Hill-Rom pay dividends? What is the dividend yield for Hill-Rom?

Hill-Rom declared a quarterly dividend on Thursday, May 7th. Stockholders of record on Friday, June 19th will be paid a dividend of $0.22 per share on Tuesday, June 30th. This represents a $0.88 annualized dividend and a yield of 0.86%. The ex-dividend date is Thursday, June 18th. View Hill-Rom's dividend history.

What price target have analysts set for HRC?

5 brokerages have issued 1-year price objectives for Hill-Rom's stock. Their forecasts range from $125.00 to $131.00. On average, they expect Hill-Rom's share price to reach $126.20 in the next year. This suggests a possible upside of 23.7% from the stock's current price. View analysts' price targets for Hill-Rom.

Has Hill-Rom been receiving favorable news coverage?

Headlines about HRC stock have been trending somewhat positive recently, InfoTrie Sentiment Analysis reports. The research group identifies positive and negative news coverage by monitoring more than six thousand blog and news sources. The firm ranks coverage of companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Hill-Rom earned a coverage optimism score of 2.0 on InfoTrie's scale. They also gave press coverage about the medical technology company a news buzz of 10.0 out of 10, indicating that recent news coverage is extremely likely to have an effect on the company's share price in the near term. View the latest news aboutHill-Rom.

Are investors shorting Hill-Rom?

Hill-Rom saw a decline in short interest during the month of May. As of May 15th, there was short interest totaling 1,640,000 shares, a decline of 11.4% from the April 30th total of 1,850,000 shares. Based on an average trading volume of 765,800 shares, the short-interest ratio is currently 2.1 days. Currently, 2.5% of the shares of the company are sold short. View Hill-Rom's Current Options Chain.

Who are some of Hill-Rom's key competitors?

What other stocks do shareholders of Hill-Rom own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Hill-Rom investors own include Steel Dynamics (STLD), Walt Disney (DIS), Paypal (PYPL), Trade Desk (TTD), Square (SQ), Twilio (TWLO), Mastercard (MA), NVIDIA (NVDA), AK Steel (AKS) and Chipotle Mexican Grill (CMG).

Who are Hill-Rom's key executives?

Hill-Rom's management team includes the following people:
  • Mr. John P. Groetelaars, Pres, CEO & Director (Age 52)
  • Mr. Carlos Alonso-Marum, Sr. VP & Pres of International (Age 60)
  • Mr. Paul Johnson, Sr. VP & Pres of Patient Support Systems (Age 54)
  • Mr. Steven J. Strobel, Sr. Advisor (Age 61)
  • Ms. Barbara W. Bodem, Sr. VP & CFO (Age 51)

What is Hill-Rom's stock symbol?

Hill-Rom trades on the New York Stock Exchange (NYSE) under the ticker symbol "HRC."

Who are Hill-Rom's major shareholders?

Hill-Rom's stock is owned by many different retail and institutional investors. Top institutional shareholders include BlackRock Inc. (10.50%), Wellington Management Group LLP (9.62%), Victory Capital Management Inc. (2.61%), State Street Corp (2.54%), Bank of New York Mellon Corp (1.55%) and Geode Capital Management LLC (1.48%). Company insiders that own Hill-Rom stock include Alton Shader, Amy M Dodrill, Andreas G Frank, Deborah Rasin and Paul Sherwood Johnson. View institutional ownership trends for Hill-Rom.

Which institutional investors are selling Hill-Rom stock?

HRC stock was sold by a variety of institutional investors in the last quarter, including BlackRock Inc., Johanson Financial Advisors Inc., Invesco Ltd., Deutsche Bank AG, Wellington Management Group LLP, Two Sigma Advisers LP, Principal Financial Group Inc., and Jennison Associates LLC. Company insiders that have sold Hill-Rom company stock in the last year include Amy M Dodrill, Andreas G Frank, Deborah Rasin, and Paul Sherwood Johnson. View insider buying and selling activity for Hill-Rom.

Which institutional investors are buying Hill-Rom stock?

HRC stock was bought by a variety of institutional investors in the last quarter, including Victory Capital Management Inc., Boston Trust Walden Corp, Ceredex Value Advisors LLC, Balyasny Asset Management LLC, Boston Trust Walden Corp, Acadian Asset Management LLC, Loomis Sayles & Co. L P, and Portolan Capital Management LLC. View insider buying and selling activity for Hill-Rom.

How do I buy shares of Hill-Rom?

Shares of HRC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Hill-Rom's stock price today?

One share of HRC stock can currently be purchased for approximately $101.98.

How big of a company is Hill-Rom?

Hill-Rom has a market capitalization of $6.79 billion and generates $2.91 billion in revenue each year. The medical technology company earns $152.20 million in net income (profit) each year or $5.08 on an earnings per share basis. Hill-Rom employs 10,000 workers across the globe.

What is Hill-Rom's official website?

The official website for Hill-Rom is www.hill-rom.com.

How can I contact Hill-Rom?

Hill-Rom's mailing address is 130 East Randolph Street Suite 1000, Chicago IL, 60601. The medical technology company can be reached via phone at 312-819-7200 or via email at [email protected]

This page was last updated on 6/5/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.